Senadé® (Senade)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceSennosides A and BSennosides A and B
Similar drugsTo uncover
  • Herbion® Laxana
    pills inwards 
    KRKA, dd, Novo mesto, AO    
  • Senadé®
    pills inwards 
    Cipla Ltd.     India
  • Senales
    pills inwards 
    Outline Pharma Pvt. Ltd.     India
  • Sennagood
    pills inwards 
    AVVA RUS, OJSC     Russia
  • Ex-Lax
    lozenges inwards 
    Novartis ExLax Inc.     Puerto Rico
    • Dosage form: & nbsppills
    Composition:

    Each tablet contains:

    Leaves of the leaves extract .... 93.33 mg (s the content of the sum of calcium salts sennosides A and B in terms of sennoside B - 13.5 mg)

    Excipients: lactose - 23.07 mg, starch 43.56 mg, methyl parahydroxybenzoate 0.04 mg, microcrystalline cellulose - 15.0 mg, talc - 11.13 mg, magnesium stearate - 0.93 mg, sodium lauryl sulfate 0.93 mg, carmellose sodium 2.00 mg.

    Description:
    Flat round tablets with bevelled edges from brown to dark brown with interspersed. On one side of the tablet, the word "CIPLA" is squashed, on the other side is the fault line.

    Pharmacotherapeutic group:laxative herbal remedy
    ATX: & nbsp

    A.06.A.B   Contact laxatives

    Pharmacodynamics:
    Has a laxative effect, coming in 8-10 hours. The laxative effect is due to the effect on the receptors of the large intestine, which increases peristalsis.

    Indications:
    constipation, caused by hypotension and sluggish peristalsis of the large intestine, regulation of the stool with hemorrhoids, proctitis, anal fissures.

    Contraindications:
    Hypersensitivity to the components of the drug, spastic constipation, intestinal obstruction, abdominal pain of unclear genesis, strangulated hernia, acute inflammatory diseases of the abdominal cavity, peritonitis, gastrointestinal and uterine bleeding, cystitis, disturbances of water-electrolyte metabolism.

    Carefully:
    appoint with liver and / or kidney disease, as well as during pregnancy and lactation, with conditions after cavitary operations, and children's age (up to 6 years) based on the dosing regimen.

    Dosing and Administration:
    Take inside usually 1 time per day in the evening before going to bed, washing down with water or some kind of drink.
    Adults and children over 12 years: 1 tablet per appointment. If there is no effect, the dose can be increased to 2-3 tablets.
    Children 6-12 years: 14 tablets and if necessary increase the dose to 1-2 tablets.
    In the process of selection, the same dose should be taken for several days and gradually increased by 14 tablets. If after reaching the maximum dose within 3 days of defecation does not occur, you need to see a doctor.

    Side effects:
    The laxative effect of the drug may be accompanied by colic pain in the abdomen, flatulence.With prolonged use, particularly at high doses, possible violations of water-electrolyte metabolism, albuminuria, hematuria, melanin deposition in the intestinal mucosa, nausea, vomiting, diarrhea, urinary discoloration, skin rash, seizures, vascular collapse, fatigue, confusion.

    Overdose:
    The main adverse effects in overdose - diarrhea, leading to dehydration. Conservative measures - increased fluid intake. This is usually enough to compensate for the loss of fluid and electrolytes. In some cases it is necessary to replenish lost fluids and electrolytes via intravenous infusion of plasma substitutes.

    Interaction:
    With prolonged use at high doses Senade® possible potentiation of cardiac glycosides and the effect on the action of drugs antiaritmichessih in connection with the possibility of the development of hypokalemia.
    While the use of thiazide diuretics, corticosteroids, licorice root drugs increases the risk of hypokalemia.

    Special instructions:
    It is not recommended to use the drug for more than 2 weeks.
    After ingestion urine can acquire brown or yellow color krasnosirenevy.

    Form release / dosage:Tablets 13.5 mg
    Packaging:
    For 20 tablets in a blister, 2 or 3 blisters together with instructions for use in a cardboard bundle.
    For 20 tablets in a blister, 25 blisters in a cardboard box with 25 instructions for use (for hospitals).

    Storage conditions:
    Store in a dry place at a temperature not exceeding 30 ° C. Keep out of the reach of children.

    Shelf life:3 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N013745 / 01
    Date of registration:19.05.2008
    The owner of the registration certificate:Cipla Ltd.Cipla Ltd. India
    Manufacturer: & nbsp
    Information update date: & nbsp16.09.2015
    Illustrated instructions
      Instructions
      Up